louisakewell, Author at European Medical Journal - Page 26 of 153

Treating Psoriasis: What Is New About Fumaric Acid Esters?

This publication covers the first session of Almirall’s 11th Skin Academy meeting in Barcelona, Spain. This year, the meeting theme was ‘The Science of…

Anti-Tumour Necrosis Factor in Inflammatory Bowel Disease: Inventory and Outlook

Biosimilars have contributed substantially to the evolving therapeutic landscape for inflammatory bowel disease (IBD), enabling healthcare systems to…

Editor's Pick: Pyruvate Kinase and Gastric Cancer: A Potential Marker

Gastric cancer is the second most common cause of cancer-related deaths worldwide, and the 5-year overall survival rate for advanced gastric cancer is ≤25%.

Slowing Progression of Airway Diseases by Smoking Cessation and Reducing Infections

The prevalence of respiratory diseases, including asthma and chronic obstructive pulmonary disease, has increased in recent decades, placing a…

Initiatives to Improve Safety of Oral Anticancer Agents Delivered by Community Pharmacists

With the recent growth in oral anticancer agents (OAA), pharmacists working in the community have recognised the urgent need to develop safe and…

Overactive Bladder in Children

Overactive bladder (OAB) is clinically defined as the presence of urinary urgency and may be associated with diurnal urinary incontinence, frequency…

Multiple Myeloma: Personalised Medicine Based on Pathogenesis

Multiple myeloma is increasingly being recognised as more than one disease, characterised by marked cytogenetic, molecular, and proliferative heterogeneity.

Modern Methods for Studying Portal Hypertension-Associated Angiogenesis in Experimental Research

Portal hypertension (PH) is associated with the majority of severe complications occurring in liver cirrhosis, and an increase in hepatic vascular…

Management of Non-Small Cell Lung Cancer: The Era of Immunotherapy

Lung cancer is the most frequently diagnosed cancer type and the leading cause of cancer-related deaths worldwide. According to the last GLOBOCAN…

Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review

As the rates of obesity increase worldwide, the prevalence of nonalcoholic fatty liver disease (NAFLD) has risen and it is now the most common cause of…